| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00 |
| filingDate |
2004-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85636615c12410a36e71eead4bbd5fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_126819b06f34b71daaa389105f438fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c877cd5f3e3d1693817ca5555b717a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1b13c52d5d2891347c9170eaf8f9d55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a269773a695bc67fd4e38fcf025a788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2db3b6f2a4781e386234593dc2acf12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca18db9f6eb466d9c540e208b783791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ebb206e1873053e4b0ac18039f7c6a |
| publicationDate |
2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1668011-B1 |
| titleOfInvention |
Hiv replication inhibiting purine derivatives |
| abstract |
The present invention relates to the use of a compound of formula (I) for the manufacture of a medicament for the prevention or the treatment of HIV infection wherein the compound of formula (I) is a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein A and B each represents a radical of formula (a) or (b) and wherein -C-D- represents a bivalent radical of formula -N=CH-NR17- (c-1); or -NR17-CH=N- (c-2); provided that when A represents a radical of formula (a) then B represents a radical of formula (b) and when A represents a radical of formula (b) then B represents a radical of formula (a). |
| priorityDate |
2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |